Studies have shown that chemotherapeutic agents such as Pt also activate the cGAS–STING pathway, which can be enhanced by damaging DNA in tumor cells and releasing it into the cytoplasm, where it binds to cGAS, activates the cGAS–STING pathway, and improves the effect of immunotherapy. The gene discussed is STING1; the disease is neoplasm.